ATE285475T1 - Msrv1 virus der mit multipler sklerose verbunden ist, seine nukleären bestandteile und verwendungen - Google Patents
Msrv1 virus der mit multipler sklerose verbunden ist, seine nukleären bestandteile und verwendungenInfo
- Publication number
- ATE285475T1 ATE285475T1 AT95420027T AT95420027T ATE285475T1 AT E285475 T1 ATE285475 T1 AT E285475T1 AT 95420027 T AT95420027 T AT 95420027T AT 95420027 T AT95420027 T AT 95420027T AT E285475 T1 ATE285475 T1 AT E285475T1
- Authority
- AT
- Austria
- Prior art keywords
- multiple sclerosis
- agent
- variant
- msrv1
- virus associated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/912—Absidia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9401531A FR2715939B1 (fr) | 1994-02-04 | 1994-02-04 | Virus MSRV2 associé à la sclérose en plaques, et ses constituants nucléiques. |
FR9401529A FR2715936B1 (fr) | 1994-02-04 | 1994-02-04 | Virus MSRV1 associé à la sclérose en plaques, et ses constituants nucléiques. |
FR9401532A FR2715937A1 (fr) | 1994-02-04 | 1994-02-04 | Virus MSRV1 et MSRV2 associés ensemble à la sclérose en plaques et leurs constituants nucléiques. |
FR9401530A FR2715938B1 (fr) | 1994-02-04 | 1994-02-04 | Constituants nucléiques du virus MSRV1, associé à la sclérose en plaques. |
FR9414322A FR2727428B1 (fr) | 1994-11-24 | 1994-11-24 | Virus msrv1 associe a la sclerose en plaques et ses constituants nucleiques |
FR9415810A FR2728585A1 (fr) | 1994-12-23 | 1994-12-23 | Virus msrv1 et agent pathogene et/ou infectant msrv2 associes a la sclerose en plaques et leurs constituants nucleiques |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE285475T1 true ATE285475T1 (de) | 2005-01-15 |
Family
ID=27546415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95420027T ATE285475T1 (de) | 1994-02-04 | 1995-02-06 | Msrv1 virus der mit multipler sklerose verbunden ist, seine nukleären bestandteile und verwendungen |
Country Status (12)
Country | Link |
---|---|
US (6) | US5871996A (de) |
EP (1) | EP0674004B1 (de) |
JP (1) | JP3611856B2 (de) |
AT (1) | ATE285475T1 (de) |
AU (1) | AU704440B2 (de) |
CA (1) | CA2141907A1 (de) |
DE (2) | DE69533863T2 (de) |
ES (1) | ES2233936T3 (de) |
FI (1) | FI954699A (de) |
NO (1) | NO953925L (de) |
NZ (1) | NZ279855A (de) |
WO (1) | WO1995021256A1 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU704440B2 (en) | 1994-02-04 | 1999-04-22 | Bio Merieux | MSRV1 virus and MSRV2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same |
FR2731356B1 (fr) * | 1995-03-09 | 1997-04-30 | Bio Merieux | Virus msrv-1 et agent pathogene et/ou infectant msrv-2 associes a la polyarthrite rhumatoide |
FR2737500B1 (fr) | 1995-08-03 | 1997-08-29 | Bio Merieux | Materiel viral et fragments nucleotidiques associes a la sclerose en plaques, a des fins de diagnostic, prophylactiques et therapeutiques |
US6771381B1 (en) | 1998-11-13 | 2004-08-03 | Laurence C. Klein | Distributed computer architecture and process for virtual copying |
US6582703B2 (en) | 1996-11-26 | 2003-06-24 | Bio Merieux | Isolated nucleotide sequences associated with multiple sclerosis or rheumatoid arthritis and a process of detecting |
US6348201B2 (en) * | 1997-05-30 | 2002-02-19 | Kibun Food Chemifa Co., Ltd. | External composition for skin comprising sphingoglycolipid |
FR2765588A1 (fr) * | 1997-07-07 | 1999-01-08 | Bio Merieux | Materiel nucleique retroviral et fragments nucleotidiques notamment associes a la sclerose en plaques et/ou la polyarthrite rhumatoide, a des fins de diagnostic, prophylactiques et therapeutiques |
US20070067859A1 (en) * | 1997-07-14 | 2007-03-22 | Michel Georges | Double-muscling in mammals |
PT2045322E (pt) * | 1997-07-14 | 2015-10-16 | Université de Liège | Musculatura dupla em mamíferos |
US6103466A (en) * | 1997-07-14 | 2000-08-15 | University Of Liege | Double-muscling in mammals |
JP2002511277A (ja) * | 1998-04-08 | 2002-04-16 | エムエス・リサーチ・アクティーゼルスカブ | 多発性硬化症および他の脱髄性疾患の診断 |
FR2780069B1 (fr) * | 1998-06-23 | 2002-06-28 | Inst Nat Sante Rech Med | Famille de sequences nucleiques et de sequences proteiques deduites presentant des motifs retroviraux endogenes humains et leurs applications |
FR2788784A1 (fr) | 1999-01-21 | 2000-07-28 | Bio Merieux | Fragment nucleique endogene associe a une maladie auto-immune, procede de marquage et reactif |
EP1029917A1 (de) | 1999-02-15 | 2000-08-23 | Bio Merieux | Die LTR-Region von MSRV und die durch sie kodierten Proteine, und Sonden und Methoden für Detektion des MSRV-1 Retrovirus |
WO2000060127A1 (en) * | 1999-04-01 | 2000-10-12 | Alton Ochsner Medical Foundation | Retrovirus associated with primary sclerosing cholangitis |
US6787303B1 (en) | 1999-04-01 | 2004-09-07 | Alton Ochsner Medical Foundation | Identification of a novel retrovirus associated with primary sclerosing cholangitis and autoimmune hepatitis |
DE19921419A1 (de) * | 1999-05-08 | 2000-11-16 | Univ Ruprecht Karls Heidelberg | Verfahren zum spezifischen Nachweis und zur Identifizierung retroviraler Nukleinsäuren / Retroviren in einem Untersuchungsgut |
DE60232660D1 (de) * | 2001-07-03 | 2009-07-30 | Genentech Inc | Humane dr4-antikörper und deren anwendungen |
US20040175715A1 (en) * | 2001-08-21 | 2004-09-09 | Burgoyne Leigh A. | Method and device for simultaneously molecularly cloning and polylocus profiling of genomes or genomes mixtures |
FR2865403B1 (fr) | 2004-01-23 | 2009-06-12 | Biomerieux Sa | Composition pour le traitement d'une pathologie associee a la msrv/herv-w |
EP1774037B1 (de) * | 2004-08-06 | 2011-05-11 | Genentech, Inc. | Assays und verfahren unter verwendung von biomarkern |
CA2575152A1 (en) | 2004-08-06 | 2006-02-16 | Genentech, Inc. | Method for predicting sensitivity of mammalian cells to apo2l/trail comprising deletion of biomarker expression |
CN101048428A (zh) * | 2004-09-08 | 2007-10-03 | 健泰科生物技术公司 | 利用死亡受体配体和cd20抗体的方法 |
WO2006029224A2 (en) * | 2004-09-08 | 2006-03-16 | Genentech, Inc. | Methods of using death receptor ligands and cd20 antibodies |
JO3000B1 (ar) | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
US8029783B2 (en) * | 2005-02-02 | 2011-10-04 | Genentech, Inc. | DR5 antibodies and articles of manufacture containing same |
EP1915626B1 (de) | 2005-08-16 | 2011-11-09 | Genentech, Inc. | Apoptosesensitivität gegenüber apo2l/trail mittels testen auf galnac-t14-expression in zellen/gewebe |
WO2010030931A1 (en) * | 2008-09-11 | 2010-03-18 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Oligonucleotides targeting human endogenous retrovirus 9 (erv-9) long terminal repeat (ltr) and methods of use |
US20140178398A1 (en) | 2011-05-03 | 2014-06-26 | Genentech, Inc | Vascular disruption agents and uses thereof |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1133829A (en) * | 1978-08-24 | 1982-10-19 | Neil J.L. Gilmour | Pasteurellosis vaccines |
US4311686A (en) * | 1979-04-30 | 1982-01-19 | The Immunology Development Corporation | Methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis |
US4396600A (en) * | 1980-12-18 | 1983-08-02 | Gus Gallucci | Adult schistosome worm-derived antigenic substance and method of obtaining same |
US4388298A (en) * | 1982-07-14 | 1983-06-14 | The United States Of America As Represented By The Secretary Of Agriculture | Propagation of hemorrhagic enteritis virus in a turkey cell line and vaccine produced |
GB8324800D0 (en) * | 1983-09-15 | 1983-10-19 | Pasteur Institut | Antigens |
US4520113A (en) * | 1984-04-23 | 1985-05-28 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions |
US4647773A (en) * | 1984-04-23 | 1987-03-03 | The United States Of America As Represented By The Department Of Health And Human Services | Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS |
NZ218050A (en) * | 1985-11-13 | 1989-05-29 | Wistar Inst | Test for the presence of htlv-1v |
US4900553A (en) * | 1987-09-11 | 1990-02-13 | Case Western Reserve University | Method of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes |
EP0326395A2 (de) * | 1988-01-29 | 1989-08-02 | City Of Hope | Verfahren zum Nachweis und zur Identifizierung von bestimmten viralen Sequenzien |
FR2651581B1 (fr) * | 1989-09-06 | 1994-05-13 | Centre Nal Recherc Scientifique | Moyens pour le diagnostic de neuropathies demyelinisantes, en particulier de la sclerose en plaques. |
US5219837A (en) * | 1990-06-21 | 1993-06-15 | Trustees Of The University Of Pennsylvania | Method of stimulating myelination of cells |
US5158976A (en) * | 1990-10-29 | 1992-10-27 | The Children's Medical Center Corporation | Controlling glutamine/glutamate related neuronal injury |
DK173091D0 (da) * | 1991-10-11 | 1991-10-11 | Schleroseforeningen The Danish | Biologisk materiale |
FR2689521B1 (fr) * | 1992-04-03 | 1996-07-19 | Bio Merieux | Procede d'obtention et maintien d'une culture cellulaire viable, infectee par un virus associe a la sclerose en plaques, et produits biologiques derives de ladite culture. |
FR2689520B1 (fr) * | 1992-04-03 | 1996-07-19 | Bio Merieux | Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques. |
EP0642585B1 (de) * | 1992-05-18 | 2005-12-28 | Genentech, Inc. | Aktivierung von Rezeptoren fähig zur Oligomerisierung durch Verwendung von fusionierten Rezeptor Liganden |
GB9310657D0 (en) * | 1993-05-24 | 1993-07-07 | Univ London | Retrovirus |
AU704440B2 (en) | 1994-02-04 | 1999-04-22 | Bio Merieux | MSRV1 virus and MSRV2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same |
FR2716198B1 (fr) | 1994-02-15 | 1996-04-19 | Bio Merieux | Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification. |
-
1995
- 1995-02-06 AU AU17114/95A patent/AU704440B2/en not_active Ceased
- 1995-02-06 JP JP52042695A patent/JP3611856B2/ja not_active Expired - Lifetime
- 1995-02-06 ES ES95420027T patent/ES2233936T3/es not_active Expired - Lifetime
- 1995-02-06 DE DE69533863T patent/DE69533863T2/de not_active Expired - Lifetime
- 1995-02-06 DE DE0674004T patent/DE674004T1/de active Pending
- 1995-02-06 WO PCT/FR1995/000142 patent/WO1995021256A1/fr active Application Filing
- 1995-02-06 US US08/384,137 patent/US5871996A/en not_active Expired - Lifetime
- 1995-02-06 AT AT95420027T patent/ATE285475T1/de not_active IP Right Cessation
- 1995-02-06 NZ NZ279855A patent/NZ279855A/en unknown
- 1995-02-06 CA CA002141907A patent/CA2141907A1/fr not_active Abandoned
- 1995-02-06 EP EP95420027A patent/EP0674004B1/de not_active Expired - Lifetime
- 1995-06-06 US US08/471,969 patent/US5871745A/en not_active Expired - Lifetime
- 1995-06-06 US US08/471,724 patent/US5800980A/en not_active Expired - Lifetime
- 1995-06-06 US US08/470,006 patent/US5962217A/en not_active Expired - Lifetime
- 1995-10-03 FI FI954699A patent/FI954699A/fi unknown
- 1995-10-03 NO NO953925A patent/NO953925L/no not_active Application Discontinuation
-
1998
- 1998-08-13 US US09/133,411 patent/US6342383B1/en not_active Expired - Lifetime
- 1998-11-30 US US09/200,990 patent/US6184025B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU704440B2 (en) | 1999-04-22 |
US5800980A (en) | 1998-09-01 |
NO953925L (no) | 1995-12-04 |
US5871745A (en) | 1999-02-16 |
ES2233936T3 (es) | 2005-06-16 |
US6184025B1 (en) | 2001-02-06 |
CA2141907A1 (fr) | 1995-08-05 |
EP0674004A1 (de) | 1995-09-27 |
FI954699A0 (fi) | 1995-10-03 |
NZ279855A (en) | 1998-05-27 |
US5962217A (en) | 1999-10-05 |
FI954699A (fi) | 1995-10-03 |
JP3611856B2 (ja) | 2005-01-19 |
EP0674004B1 (de) | 2004-12-22 |
DE69533863T2 (de) | 2006-02-16 |
NO953925D0 (no) | 1995-10-03 |
DE69533863D1 (de) | 2005-01-27 |
JPH08511170A (ja) | 1996-11-26 |
US6342383B1 (en) | 2002-01-29 |
US5871996A (en) | 1999-02-16 |
DE674004T1 (de) | 1996-09-19 |
WO1995021256A1 (fr) | 1995-08-10 |
AU1711495A (en) | 1995-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE285475T1 (de) | Msrv1 virus der mit multipler sklerose verbunden ist, seine nukleären bestandteile und verwendungen | |
IT8748330A0 (it) | Copolimero promotore del rilascio di sudiciume,procedimento di produzione e composizione detergente contenente detto copolimero | |
EP0608261A4 (de) | Zusammensetzung aus einem immunreaktiven hepatitis-c-virus-polypeptid. | |
TR26643A (tr) | Yeni bilesimler, bunlarin hazirlanmasi icin prosesler, bunlari ihtiva eden terkipler ve bunlarin herbisidler olarak kullanilmasi. | |
TR26619A (tr) | YENI BILESIKLER,BUNLARIN HAZIRLANMALARINA YÖNELIK ISLEMLER,BUNLARI ICEREN BILESIMLER VE BUNLARIN ZARARLI OT ÖLDüRüCüSü(HERBISIDAL) OLARAK KULLANI- MI. | |
Bray | Reactive patterns in families of the severely disabled. | |
AU6070390A (en) | Compositions derived from bi4v2o11 | |
NO912992D0 (no) | 1-aminopropandiol-2,3 med hoey renhet, samt fremgangsmaate for fremstilling av forbindelsen. | |
IT7927919A0 (it) | Benzamidi ad attivita' anestetica locale e antiaritmica, processo per la loro preparazione e composizione farmaceutiche che le contengono. | |
IT8424227A0 (it) | Acilammino mitosani ad attivita'antitumorale e relativo procedimento di preparazione. | |
ATE98721T1 (de) | Schienenlager. | |
AU3049589A (en) | Preparation for fixing and care of the hair | |
DE59105603D1 (de) | Monoklonale antikörper gegen den interleukin 2-rezeptor. | |
NO964760L (no) | MSRV-1-virus og patogent og/eller infeksiöst MSRV-2-middel forbundet med reumatoid artritt | |
CA2143325A1 (en) | Cloning and expression of .beta.app-c100 receptor | |
TR200001135T2 (tr) | Dofetilid polimorfları. | |
ATE319831T1 (de) | Neue polypeptide mit toxischer aktivität gegen insekten der familie der dipteren | |
EP0464416A3 (en) | New strains of drechslera spp., and weed control agents and weed control compositions containing the same | |
SU834553A1 (ru) | Цифровой вольтметр-электрометр | |
IT8520574A0 (it) | Azionatore abbassabile per i dispositivi di manovra e di regolazione disposti dietro lo schermo protettivo dell'inseritore di apparecchi domestici. | |
ATE134988T1 (de) | Neue vorangeordnete sechszähnige liganden verwendbar in röntgenologischen bildformenden wirkstoffen | |
Romano | Experience drives corporate AIDS policies | |
DE59101258D1 (de) | Fluormethylierte Polycyanbenzole, deren Alkalicyanid-Addukte, Verfahren zu ihrer Herstellung und Verwendung der fluormethylierten Polycyanbenzole. | |
SU834585A1 (ru) | Цифровой анализатор | |
ES2010464A6 (es) | Procedimiento para la preparacion de un compuesto antivirico conteniendo dionas policiclicas aromaticas y analogos de nucleosidos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |